Latest Research Reports

Novartis, Pfizer, Amgen, and Merck: key players in the autoimmune biosimilars space

Novartis, Pfizer, Amgen, and Merck: key players in the autoimmune biosimilars space

EMA set to approve plethora of oncology drugs

EMA set to approve plethora of oncology drugs

Orphan cancer drugs take up 37% of market share

Orphan cancer drugs take up 37% of market share

The launch of long-acting therapies will drive the growth of the growth hormone deficiency Market

The launch of long-acting therapies will drive the growth of the growth hormone deficiency Market

Licensing deals in Duchenne Muscular Dystrophy (DMD)

Licensing deals in Duchenne Muscular Dystrophy (DMD)

China shows leading emerging market growth in R&D spend

While the global pharmaceutical markets have typically been dominated by US, Europe and Japan, emerging markets have been steadily increasing their prominence in the global space over the...

China shows leading emerging market growth in R&D spend

Innovative new drugs could produce a watershed moment for dermatology sufferers

Innovative new drugs could produce a watershed moment for dermatology sufferers

Pharma licensing deals 2016/2017 comparison

Pharma licensing deals 2016/2017 comparison

Top oncology revenue generators: what will the next five years bring?

Top oncology revenue generators: what will the next five years bring?

Non-profit licensing deal values climb in 2016

In 2016, there was a surge in deal values between the biopharmaceutical industry and non-profit...

Non-profit licensing deal values climb in 2016

Report: Novel pipeline products to drive schizophrenia market growth

Report: Novel pipeline products to drive schizophrenia market growth

Report: Quadrivalent vaccines and rising immunisation recommendations to drive growth of seasonal influenza vaccines

Developed nations expanding vaccination recommendations against seasonal influenza and growth of egg-based quadrivalent seasonal influenza vaccines are expected to increase growth of the...

Report: Quadrivalent vaccines and rising immunisation recommendations to drive growth of seasonal influenza vaccines